Although our demonstration that seizure susceptibility is enhanced in Nrp2 deleted mice is of potential clinical relevance, the two studies that identified Nrp2 polymorphisms in humans with ASD [16, 17] explicitly exclude subjects with other neurological disorders making it difficult to assess seizures/epilepsy in their patient population. This evidence concerns the gene NRP2 and epilepsy.